首页>
外国专利>
Oral Pharmaceutical composition for the Prevention and Treatment of oxidative stress that is a consequence of the treatment of hemodialysis in patients with chronic renal failure in the form of Medical Device, Kit and Method for the Prevention and Treatment of this oxidative stress
Oral Pharmaceutical composition for the Prevention and Treatment of oxidative stress that is a consequence of the treatment of hemodialysis in patients with chronic renal failure in the form of Medical Device, Kit and Method for the Prevention and Treatment of this oxidative stress
Describes an oral Pharmaceutical composition containing cystine or cysteine glutathione for Treatment and Prevention of oxidative stress that occurs as a result of treatment by hemodialysis in patients with chronic renal failure.Composition for oral cysteine or its oxidized form in disulfide (cystine), mixed with a sufficient amount of glutathione for Treatment and Prevention of oxidative stress derived from treatment by hemodialysis in patients with chronic renal failure.It also refers to a medical device in the form of a kit that includes a Unit amount of the above Composition and a Second composition constituted only by cystine or cysteine, such compositions are suitable for be supplied separately to a patient under TR Attachment by haemodialysis, to increaseIn the initial phase of extracorporeal circulation, the level of glutathione in the shortest Time possible, to respond quickly to oxidative stress which is a consequence of the treatment by hemodialysis.
展开▼
